DexCom had one patents in 3D printing during Q4 2023. DexCom Inc has developed systems and methods for a continuous analyte sensor, specifically for continuous glucose monitoring. The system includes first and second working electrodes to measure additional signals, providing background and sensitivity measurements for processing sensor data and triggering events like digital filtering or suspending data display. GlobalData’s report on DexCom gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights DexCom Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

DexCom grant share with 3D printing as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Dual electrode system for a continuous analyte sensor (Patent ID: US20230380734A1)

The patent filed by DexCom Inc. discloses systems and methods for a continuous analyte sensor, specifically a continuous glucose sensor. The system utilizes two working electrodes to measure additional analyte or non-analyte related signals, providing background and sensitivity measurements for processing sensor data and triggering events like digital filtering or suspending data display. The method involves measuring signals related to glucose and non-glucose compounds, monitoring changes in non-glucose compounds over time, and calibrating the sensor based on these changes. The system includes working electrodes, a processor module, and a subtraction module to generate differential signals for glucose sensor data points. It also involves calibrating the system based on changes in non-glucose compounds, determining glucose transport stability, and filtering data points accordingly.

The patent claims cover methods for measuring sensitivity changes in a glucose sensor over time, calibrating the sensor based on non-glucose compound changes, and determining glucose transport stability. The system includes working electrodes, a processor module, and a subtraction module for generating differential signals. It also involves calibrating the system based on non-glucose compound changes, determining glucose transport stability, and filtering data points as needed. The invention aims to improve the accuracy and reliability of continuous analyte sensors by incorporating additional measurements and calibration processes based on non-glucose compounds.

To know more about GlobalData’s detailed insights on DexCom, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.